학술논문
A Data-Driven Approach to Define Parsimonious Eligibility Criteria in First-Line Clinical Trials for Diffuse Large B-Cell Lymphoma
Document Type
Abstract
Author
Source
In Blood 13 November 2019 134 Supplement 1:3416-3416
Subject
Language
ISSN
0006-4971